FIGURE

Figure 6.

ID
ZDB-FIG-240111-36
Publication
Heins-Marroquin et al., 2024 - CLN3 deficiency leads to neurological and metabolic perturbations during early development
Other Figures
All Figure Page
Back to All Figure Page
Figure 6.

Validation of glycerophosphodiester and amino acid changes by targeted LC-MS analyses.

(A) Metabolite levels of glycerophosphodiester species (GPE, GPI, GPS, GPG, and GPC) extracted from batches of 10 whole zebrafish larvae at 5 dpf (n = 40 larvae for each genotype). (B) Representative MS/MS spectrum plots of GPI and GPC from MUT1 extracts (in blue) and metabolite standards (in red), further confirming compound identities (matching library score 83%, isotopic pattern score 100%). (A, C) Metabolite levels of the same glycerophosphodiester species as shown in panel (A), but extracted from human iPSC-derived cerebral organoids after 55 d of differentiation (n = 4). (D) Metabolite levels of amino acids differing significantly between WT and MUT1 zebrafish larvae at 5 dpf based on targeted LC-MS measurements. Data shown are means ± SDs of eight biological replicates for WT1/MUT1 (n = 200 larvae per genotype) and four biological replicates for WT2/MUT2 (n = 40 larvae per genotype). Statistically significant differences between WT and mutant zebrafish samples were determined using multiple comparison one-way ANOVA followed by Tukey’s correction, and for iPSC samples, an unpaired t test was used (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; and ns, not significant).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Life Sci Alliance